1. Home
  2. Labeler Index
  3. Pharmacia & Upjohn Company Llc
  4. 0009-0370
  5. NDC Package Code: 0009-0370-03 Flavored Colestid

NDC Package 0009-0370-03 Flavored Colestid

Colestipol Hydrochloride Granule, For Suspension Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0009-0370-03
Package Description:
2 CARTON in 1 CARTON / 60 PACKET in 1 CARTON / 7.5 g in 1 PACKET
Product Code:
0009-0370
Proprietary Name:
Flavored Colestid
Non-Proprietary Name:
Colestipol Hydrochloride
Substance Name:
Colestipol Hydrochloride
Usage Information:
Since no drug is innocuous, strict attention should be paid to the indications and contraindications, particularly when selecting drugs for chronic long-term use.COLESTID Granules and FLAVORED COLESTID Granules are indicated as adjunctive therapy to diet for the reduction of elevated serum total and low-density lipoprotein (LDL) cholesterol in patients with primary hypercholesterolemia (elevated low density lipoproteins [LDL] cholesterol) who do not respond adequately to diet. Generally, COLESTID and FLAVORED COLESTID have no clinically significant effect on serum triglycerides, but with its use triglyceride levels may be raised in some patients.Therapy with lipid-altering agents should be a component of multiple risk factor intervention in those individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. Treatment should begin and continue with dietary therapy (see NCEP guidelines). A minimum of six months of intensive dietary therapy and counseling should be carried out prior to initiation of drug therapy. Shorter periods may be considered in patients with severe elevations of LDL-C or with definite CHD.According to the NCEP guidelines, the goal of treatment is to lower LDL-C, and LDL-C is to be used to initiate and assess treatment response. Only if LDL-C levels are not available, should the Total-C be used to monitor therapy. The NCEP treatment guidelines are shown below.LDL-Cholesterolmg/dL (mmol/L)Definite Atherosclerotic DiseaseCoronary heart disease or peripheral vascular disease (including symptomatic carotid artery disease).Two or More Other Risk FactorsOther risk factors for coronary heart disease (CHD) include: age (males: ≥45 years; females: ≥55 years or premature menopause without estrogen replacement therapy); family history of premature CHD; current cigarette smoking; hypertension; confirmed HDL-C <35 mg/dL (0.91 mmol/L); and diabetes mellitus. Subtract one risk factor if HDL-C is ≥60 mg/dL (1.6 mmol/L).Initiation LevelGoalNoNo≥190(≥4.9)<160(<4.1)NoYes≥160(≥4.1)<130(<3.4)YesYes or No≥130(≥3.4)≤100(≤2.6)
11-Digit NDC Billing Format:
00009037003
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 1048450 - colestipol HCl 5 GM Granules For Oral Suspension
  • RxCUI: 1048450 - colestipol hydrochloride 5000 MG Granules for Oral Suspension
  • RxCUI: 1048450 - colestipol hydrochloride 5 GM Granules For Oral Suspension
  • RxCUI: 1048452 - Colestid 5 GM Granules For Oral Suspension
  • RxCUI: 1048452 - colestipol hydrochloride 5000 MG Granules for Oral Suspension [Colestid]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Pharmacia & Upjohn Company Llc
    Dosage Form:
    Granule, For Suspension - A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • COLESTIPOL HYDROCHLORIDE 5 g/7.5g
    • Pharmacologic Class(es):
  • Bile Acid Sequestrant - [EPC] (Established Pharmacologic Class)
  • Bile-acid Binding Activity - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    NDA017563
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    06-01-1977
    End Marketing Date:
    04-30-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0009-0370-03?

    The NDC Packaged Code 0009-0370-03 is assigned to a package of 2 carton in 1 carton / 60 packet in 1 carton / 7.5 g in 1 packet of Flavored Colestid, a human prescription drug labeled by Pharmacia & Upjohn Company Llc. The product's dosage form is granule, for suspension and is administered via oral form.This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package.

    Is NDC 0009-0370 included in the NDC Directory?

    Yes, Flavored Colestid with product code 0009-0370 is active and included in the NDC Directory. The product was first marketed by Pharmacia & Upjohn Company Llc on June 01, 1977.

    What is the NDC billing unit for package 0009-0370-03?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 0009-0370-03?

    The 11-digit format is 00009037003. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20009-0370-035-4-200009-0370-03